Latest S-1 registration statements

Tenax Therapeutics aims to raise up to $12 million through a public offering of common stock, warrants, and pre-funded warrants to advance its oral levosimendan (TNX-103) Phase 3 trial for pulmonary hypertension with heart failure and preserved ejection fraction (PH-HFpEF).

EzFill Holdings, Inc. has filed Amendment No. 3 to its Form S-1 registration statement with the SEC, primarily focusing on exhibits related to the proposed public offering.

Sunshine Biopharma is launching a firm commitment, underwritten public offering of units to raise capital for general corporate purposes, including advancing its oncology and antiviral drug pipeline.

Unusual Machines, Inc. plans a $5 million initial public offering to fund the acquisition of Fat Shark and Rotor Riot, aiming to become a leader in the FPV drone technology market.

AgEagle Aerial Systems is registering for the resale of up to 16,319,165 warrant shares by selling shareholders, potentially generating $1.6 million upon exercise.

MSP Recovery has filed an amendment to its Form S-1 registration statement related to the potential sale of up to 50,000,000 shares of Class A Common Stock by a selling stockholder.

Ealixir Inc., an online reputation management company, has filed an amendment to its S-1 registration statement for a proposed public offering of its common stock.

Ispire Technology Inc. plans to offer up to 2,272,727 shares of common stock at an assumed price of $11.00 per share.

Spectaire Holdings Inc. files an amendment to its Form S-1 registration statement, covering the potential issuance and resale of common stock and warrants.

Spectaire Holdings Inc. files an amendment to its Form S-1 registration statement related to the potential sale of up to 3,067,438 shares of common stock by Keystone Capital Partners, LLC.

Kyverna Therapeutics is seeking to raise approximately $182.3 million through an initial public offering to further the clinical development of its cell therapies for autoimmune diseases.

Safe & Green Holdings Corp. is registering for resale up to 3,510,302 shares of its common stock by existing stockholders, including shares issuable upon conversion of a debenture and exercise of a warrant.

Expion360 files an amendment to its Form S-1 registration statement to register the resale of up to 1,781,978 shares of common stock by Tumim Stone Capital, LLC, pursuant to an equity line purchase agreement.

180 Life Sciences Corp. is registering for resale up to 13.95 million shares of its common stock potentially issuable upon the exercise of existing warrants held by a selling stockholder.

Aclarion files an amendment to its S-1 registration statement to allow White Lion Capital to resell up to 2,500,000 shares of common stock, while addressing Nasdaq compliance and going concern uncertainties.

Abacus Life, Inc. plans to offer additional 9.875% fixed-rate senior notes due 2028 to refinance debt and for general corporate purposes.

Inspire Veterinary Partners is registering for resale up to 7,869,182 shares of its Class A common stock by selling stockholder Tumim Stone Capital LLC, potentially generating up to $30 million in gross proceeds for the company.

Armlogi Holding Corp. has filed an amendment to its Form S-1 registration statement, signaling progress towards its initial public offering and Nasdaq listing.

GRI Bio launches a public offering of common stock and warrants aiming to raise $8 million for clinical trials and Nasdaq compliance.

Invech Holdings, Inc. files an S-1 registration statement for the resale of up to 2,462,293 shares of its common stock by existing shareholders.

SeqLL Inc. files an amendment to its registration statement for a $20 million unit offering and details its proposed merger with Lyneer Investments LLC.

BIOLASE, Inc., a leading provider of advanced laser systems for the dental industry, is offering up to $7.48 million in units and pre-funded units in a best efforts offering.

Nuwellis, Inc. announces a proposed offering of up to 16,326,530 units to raise up to $8 million for working capital and commercialization.

GRI Bio launches a public offering of common stock and warrants to raise up to $8 million as it faces Nasdaq listing deficiencies and aims to fund clinical trials.

IB Acquisition Corp., a blank check company, files an amendment to its S-1 registration statement for a proposed $100 million initial public offering.

BIO-key International is registering the resale of up to 436,509 shares of its common stock by a selling stockholder, Dillon Hill Investment Company LLC, with the company not receiving any proceeds from the sale.

Bone Biologics Corporation is seeking to raise capital through a public offering of common stock, pre-funded warrants, and common warrants, aiming to fund clinical trials and extend its patent portfolio.

Chromocell Therapeutics aims to raise capital for pain therapeutics development through an initial public offering.

Artificial Intelligence Technology Solutions (AITX) has filed a registration statement for the resale of up to one billion shares of its common stock by GHS Investments, LLC, potentially generating up to $8 million in gross proceeds for the company.

Revelation Biosciences files an amendment to its S-1 registration statement for a proposed public offering of common stock and warrants.